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-chromosome. Subsequently he used autotransplants in chronic phase to try to delay blastic transformation. Prof Goldman then moved to allotransplants, where he developed the largest CML transplant programme in Europe. More recently he promoted the use of imatinib and other tyrosine kinase inhibitors, and he and colleagues at the Hammersmith Hospital played an important role in proving the efficacy of these agents.
John Goldman was the son of Carl Heinz Goldman, a Jewish doctor who fled Germany in 1933 with his young wife Berthe' to escape the Nazis' racial laws. He arrived in London with a fivepound note, his wife's jewels sewed into her clothes and a letter of introduction. He quickly established a successful Harley Street surgery and would later treat Elizabeth Taylor, Rex Reed and Kay Kendall. Carl Heinz served in the British Army in WW II after, paradoxically, detention as an enemy alien.
John was born in 1938 and educated at Westminster School, where he was a King's Scholar but was not allowed to sing at the coronation of Queen Elizabeth II, nominally because of his religion, but perhaps also because of his vocal talents! He went up to Magdalen College, Oxford, on a Classics scholarship, but quickly transferred to psychology and physiology and completed his medical training at St Bartholomew Hospital, London. After initial training in North London he moved to the University of Miami and later to Massachusetts General Hospital. His initial training was in surgery, oncology and radiation therapy, but he soon realized his true love was haematology.
In 1970 In the 1990s Goldman focused on promising research on imatinib, a tyrosine kinase inhibitor directed towards the genetic mutation causing the disease defined in 1983 by Profs Eli Canaani, Robert Peter Gale and others. The drug worked brilliantly in preclinical studies done by Prof Brian Druker, but no drug company was willing to develop it because of a perceived limited commercial incentive. Much like Sirs Howard Florey and Ernest Chain who developed penicillin following its discovery by Sir Alexander Fleming, but had to travel to the United States to find a drug company willing to produce it despite the potential to alter the course of WW II, Goldman flew to Basel to persuade Novartis to manufacture imatinib. He succeeded, and imatinib and successor tyrosine kinase inhibitors have extended the lives of tens of thousands of people worldwide.
Goldman was a founder and president of several professional organizations promoting research and collaboration in blood disorders and transplantation, including the European Hematology Association, Among his professional colleagues, Prof Goldman was considered the leader in his field. He published over 800 scientific papers and many books, coordinated an international community of leukaemia researchers and fostered a climate of openness, collaboration and free intellectual exchange. He also mentored a generation of leukaemia specialists who now head haematology departments across the UK and the world. It is impossible to name them all, but the list includes Profs Jane Apperley, Nicholas Cross, Junia Melo, Andreas Hochhaus, Charles Craddock and Timothy Hughes.
John Goldman was a skilled physician with legendary devotion to his patients. He was regularly found in the early morning hours reading medical charts and reassuring sleepless people. His overseas colleagues thought nothing of calling John at 1 AM London time to discuss an idea or complex medical case; no one is certain when (or if) he ever slept.
Prof Goldman was a gentleman and scholar known by his colleagues and friends for his erudition, sense of irony, generosity and modesty. He enjoyed reading Saki, Wilde, Shakespeare, Greek mythology and histories of the Napoleonic wars. He loved skiing, spoke perfect French and passable Russian and Spanish and travelled extensively. He once drove from London to India with a group of his Oxford classmates. When their party was briefly imprisoned by Iranian authorities, they escaped by drugging their captors with barbiturates. John also tried to solve the problem of the Elgin Marbles by suggesting a duplicate set be made and that each side alternately choose the piece they wanted until two full sets were assembled. No one has come up with a better solution but the quandary remains. Apparently a trickier problem than curing CML.
John Goldman was invariably polite to colleagues, friends and acquaintances, perhaps to a fault. When people approached him with bizarre ideas or ridiculous scientific hypothesis, he was always polite, commenting: 'That's an interesting idea.' Afterwards he reminded senior colleagues of a quote from Field Marshall Arthur Wellesley, first Duke of Wellington, who having been addressed by a passerby near Apsley House as: 'Mr. Jones, I believe' replied: 'If you believe that Sir, you will believe anything'.
